{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:18:29Z","timestamp":1778775509318,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T00:00:00Z","timestamp":1426118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10792-015-0059-5","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T13:31:47Z","timestamp":1426080707000},"page":"441-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab"],"prefix":"10.1007","volume":"35","author":[{"given":"Andrea","family":"Saitta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,12]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archopht.1978.03910050204002","volume":"96","author":"JD Gass","year":"1978","unstructured":"Gass JD, Guerry RK, Jack RL, Harris G (1978) Choroidal osteoma. Arch Ophthalmol 96:428\u2013435","journal-title":"Arch Ophthalmol"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archopht.116.10.1337","volume":"116","author":"GW Aylward","year":"1998","unstructured":"Aylward GW, Chang TS, Pautler SE, Gass JD (1998) A long-term follow-up of choroidal osteoma. Arch Ophthalmol 116:1337\u20131341","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"59_CR3","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archopht.123.12.1658","volume":"123","author":"CL Shields","year":"2005","unstructured":"Shields CL, Sun H, Demirci H, Shields JA (2005) Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol 123(12):1658\u20131666","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"59_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2007.07.037","volume":"114","author":"CL Shields","year":"2007","unstructured":"Shields CL, Perez B, Materin MA, Mehta S, Shields JA (2007) Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor. Ophthalmology 114(12):53\u201358","journal-title":"Ophthalmology"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00417-007-0636-z","volume":"245","author":"H Ahmadieh","year":"2007","unstructured":"Ahmadieh H, Vafi N (2007) Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 245:1731\u20131733","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0420.2007.01136.x","volume":"87","author":"WK Song","year":"2009","unstructured":"Song WK, Koh HJ, Kwon OW, Byeon SH, Lee SC (2009) Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma. Acta Ophthalmol 87:100\u2013101. doi: 10.1111\/j.1600-0420.2007.01136.x","journal-title":"Acta Ophthalmol"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/OPTH.S13730","volume":"4","author":"N Pandey","year":"2010","unstructured":"Pandey N, Guruprasad A (2010) Choroidal osteoma with choroidal neovascular membrane: successful treatment with intravitreal bevacizumab. Clin Ophthalmol 4:1081\u20131084. doi: 10.2147\/OPTH.S13730","journal-title":"Clin Ophthalmol"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/eye.2008.313","volume":"23","author":"MH Song","year":"2009","unstructured":"Song MH, Roh YJ (2009) Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma. Eye (Lond) 23:1745\u20131746. doi: 10.1038\/eye.2008.313","journal-title":"Eye (Lond)"},{"issue":"2","key":"59_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3928\/23258160-20140306-12","volume":"45","author":"MV Carle","year":"2014","unstructured":"Carle MV, Chu TG, Liao D, Boyer DS (2014) Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with choroidal osteoma. Ophthalmic Surg Lasers Imaging Retina 45(2):169\u2013171. doi: 10.3928\/23258160-20140306-12","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"210458","DOI":"10.1155\/2014\/210458","volume":"2014","author":"AM Mansour","year":"2014","unstructured":"Mansour AM, Arevalo F, Al Kahtani E et al (2014) Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma. J Ophthalmol 2014:210458. doi: 10.1155\/2014\/210458","journal-title":"J Ophthalmol"},{"issue":"112","key":"59_CR11","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(112):2537\u20132548. doi: 10.1016\/j.ophtha.2012.09.006","journal-title":"Ophthalmology"},{"issue":"1","key":"59_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2013.02.017","volume":"156","author":"B Bakall","year":"2013","unstructured":"Bakall B, Folk JC, Boldt HC et al (2013) Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol 156(1):15\u201322. doi: 10.1016\/j.ajo.2013.02.017","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"59_CR13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/bjophthalmol-2013-303344","volume":"97","author":"H Cho","year":"2013","unstructured":"Cho H, Shah CP, Weber M, Heier JS (2013) Aflibercept for exudative AMD with persistent fluid on ranibizumab and\/or bevacizumab. Br J Ophthalmol 97(8):1032\u20131035. doi: 10.1136\/bjophthalmol-2013-303344","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"59_CR14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/IAE.0b013e31828e8551","volume":"33","author":"N Kumar","year":"2013","unstructured":"Kumar N, Marsiglia M, Mrejen S et al (2013) Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Retina 33(8):1605\u20131612. doi: 10.1097\/IAE.0b013e31828e8551","journal-title":"Retina"},{"issue":"9","key":"59_CR15","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/IAE.0000000000000187","volume":"34","author":"MA Khan","year":"2014","unstructured":"Khan MA, DeCroos FC, Storey PP, Shields JA, Garg SJ, Shields CL (2014) Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma. Retina 34(9):1750\u20131756. doi: 10.1097\/IAE.0000000000000187","journal-title":"Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-015-0059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0059-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:30:35Z","timestamp":1559262635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-015-0059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s10792-015-0059-5","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,12]]}}}